{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:50:12Z","timestamp":1793998212332,"version":"4.8.0"},"reference-count":240,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Drug reaction with eosinophilia and systemic symptoms (DRESS) is a heterogeneous, multiorgan and potentially life-threatening drug-hypersensitivity reaction (DHR) that occurs several days or weeks after drug initiation or discontinuation. DHRs constitute an emerging issue for public health, due to population aging, growing multi-organ morbidity, and subsequent enhanced drug prescriptions. DRESS has more consistently been associated with anticonvulsants, allopurinol and antibiotics, such as sulphonamides and vancomycin, although new drugs are increasingly reported as culprit agents. Reactivation of latent infectious agents such as viruses (especially Herpesviridae) plays a key role in prompting and sustaining aberrant T-cell and eosinophil responses to drugs and pathogens, ultimately causing organ damage. However, the boundaries of the impact of viral agents in the pathophysiology of DRESS are still ill-defined. Along with growing awareness of the multifaceted aspects of immune perturbation caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the ongoing SARS-CoV-2-related disease (COVID-19) pandemic, novel interest has been sparked towards DRESS and the potential interactions among antiviral and anti-drug inflammatory responses. In this review, we summarised the most recent evidence on pathophysiological mechanisms, diagnostic approaches, and clinical management of DRESS with the aim of increasing awareness on this syndrome and possibly suggesting clues for future research in this field.<\/jats:p>","DOI":"10.3390\/microorganisms11020346","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T08:56:26Z","timestamp":1675068986000},"page":"346","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2889-366X","authenticated-orcid":false,"given":"Giuseppe A.","family":"Ramirez","sequence":"first","affiliation":[{"name":"Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele, 20132 Milan, Italy"},{"name":"Faculty of Medicine, Universit\u00e0 Vita-Salute San Raffaele, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6380-0377","authenticated-orcid":false,"given":"Marco","family":"Ripa","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Universit\u00e0 Vita-Salute San Raffaele, 20132 Milan, Italy"},{"name":"Unit of Infectious Diseases, IRCCS Ospedale San Raffaele, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7302-6381","authenticated-orcid":false,"given":"Samuele","family":"Burastero","sequence":"additional","affiliation":[{"name":"Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4310-6951","authenticated-orcid":false,"given":"Giovanni","family":"Benanti","sequence":"additional","affiliation":[{"name":"Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele, 20132 Milan, Italy"},{"name":"Faculty of Medicine, Universit\u00e0 Vita-Salute San Raffaele, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Bagnasco","sequence":"additional","affiliation":[{"name":"IRCCS Policlinico San Martino, Department of Internal Medicine (DIMI), University of Genoa, 16132 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Nannipieri","sequence":"additional","affiliation":[{"name":"Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele, 20132 Milan, Italy"},{"name":"Faculty of Medicine, Universit\u00e0 Vita-Salute San Raffaele, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Monardo","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Universit\u00e0 Vita-Salute San Raffaele, 20132 Milan, Italy"},{"name":"Unit of Infectious Diseases, IRCCS Ospedale San Raffaele, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Ponta","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Universit\u00e0 Vita-Salute San Raffaele, 20132 Milan, Italy"},{"name":"Unit of Infectious Diseases, IRCCS Ospedale San Raffaele, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Asperti","sequence":"additional","affiliation":[{"name":"Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele, 20132 Milan, Italy"},{"name":"Faculty of Medicine, Universit\u00e0 Vita-Salute San Raffaele, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3677-4342","authenticated-orcid":false,"given":"Maria Bernadette","family":"Cilona","sequence":"additional","affiliation":[{"name":"Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele, 20132 Milan, Italy"},{"name":"Faculty of Medicine, Universit\u00e0 Vita-Salute San Raffaele, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Castagna","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Universit\u00e0 Vita-Salute San Raffaele, 20132 Milan, Italy"},{"name":"Unit of Infectious Diseases, IRCCS Ospedale San Raffaele, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Dagna","sequence":"additional","affiliation":[{"name":"Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele, 20132 Milan, Italy"},{"name":"Faculty of Medicine, Universit\u00e0 Vita-Salute San Raffaele, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2417-0410","authenticated-orcid":false,"given":"Mona-Rita","family":"Yacoub","sequence":"additional","affiliation":[{"name":"Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele, 20132 Milan, Italy"},{"name":"Faculty of Medicine, Universit\u00e0 Vita-Salute San Raffaele, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/imj.14134","article-title":"Trends in Adverse Drug Reaction-Related Hospitalisations over 13 Years in New South Wales, Australia","volume":"49","author":"Zhang","year":"2019","journal-title":"Intern. Med. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jaci.2016.04.029","article-title":"Trends, Characteristics, and Incidence of Anaphylaxis in 2001\u20132010: A Population-Based Study","volume":"139","author":"Lee","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"20420986221080796","DOI":"10.1177\/20420986221080796","article-title":"Ten-Year Trends in Adverse Drug Reaction-Related Hospitalizations among People with Dementia","volume":"13","author":"Zaidi","year":"2022","journal-title":"Ther. Adv. Drug Saf."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/jama.1997.03540280039031","article-title":"Adverse Drug Events in Hospitalized Patients: Excess Length of Stay, Extra Costs, and Attributable Mortality","volume":"277","author":"Classen","year":"1997","journal-title":"JAMA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/pds.1612","article-title":"The Use of an Electronic Medical Record System for Mandatory Reporting of Drug Hypersensitivity Reactions Has Been Shown to Improve the Management of Patients in the University Hospital in Korea","volume":"17","author":"Park","year":"2008","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1365-2125.2010.03774.x","article-title":"Epidemiology and Risk Factors for Drug Allergy","volume":"71","author":"Thong","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical Genetics: A Marker for Stevens-Johnson Syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.tpj.6500356","article-title":"A Marker for Stevens-Johnson Syndrome \u2026: Ethnicity Matters","volume":"6","author":"Lonjou","year":"2006","journal-title":"Pharmacogenom. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/j.1528-1167.2008.01719.x","article-title":"Carbamazepine and Phenytoin Induced Stevens-Johnson Syndrome Is Associated with HLA-B*1502 Allele in Thai Population","volume":"49","author":"Locharernkul","year":"2008","journal-title":"Epilepsia"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.0409500102","article-title":"HLA-B*5801 Allele as a Genetic Marker for Severe Cutaneous Adverse Reactions Caused by Allopurinol","volume":"102","author":"Hung","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/hmg\/ddq537","article-title":"Genome-Wide Association Study Identifies HLA-A*3101 Allele as a Genetic Risk Factor for Carbamazepine-Induced Cutaneous Adverse Drug Reactions in Japanese Population","volume":"20","author":"Ozeki","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMoa1013297","article-title":"HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans","volume":"364","author":"McCormack","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00130832-200208000-00003","article-title":"Pharmacological Interaction of Drugs with Antigen-Specific Immune Receptors: The p-i Concept","volume":"2","author":"Pichler","year":"2002","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.amjmed.2011.01.017","article-title":"The DRESS Syndrome: A Literature Review","volume":"124","author":"Cacoub","year":"2011","journal-title":"Am. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): An Original Multisystem Adverse Drug Reaction. Results from the Prospective RegiSCAR Study","volume":"169","author":"Kardaun","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1365-2133.2003.05584.x","article-title":"A 6-Month Prospective Survey of Cutaneous Drug Reactions in a Hospital Setting","volume":"149","author":"Auzerie","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/bcp.13096","article-title":"Eosinophilic Drug Reactions Detected by a Prospective Pharmacovigilance Programme in a Tertiary Hospital","volume":"83","author":"Tong","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_18","first-page":"478","article-title":"Drug Hypersensitivity Syndrome in a West-Indian Population","volume":"13","author":"Muller","year":"2003","journal-title":"Eur. J. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1016\/j.jaip.2021.05.008","article-title":"Reporting of Drug Reaction with Eosinophilia and Systemic Symptoms from 2002 to 2019 in the US Food and Drug Administration Adverse Event Reporting System","volume":"9","author":"Bluestein","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.cmi.2021.05.023","article-title":"Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in Patients with COVID-19","volume":"27","author":"Ramirez","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s13671-021-00348-z","article-title":"Updates and Insights in the Diagnosis and Management of DRESS Syndrome","volume":"10","author":"Schunkert","year":"2021","journal-title":"Curr. Dermatol. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Cho, Y.T., Yang, C.W., and Chu, C.Y. (2017). Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): An Interplay among Drugs, Viruses, and Immune System. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18061243"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.18176\/jiaci.0480","article-title":"Spanish Guidelines for Diagnosis, Management, Treatment, and Prevention of DRESS Syndrome","volume":"30","author":"Sendagorta","year":"2020","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jaad.2019.09.036","article-title":"Drug Reaction with Eosinophilia and Systemic Symptoms May Occur within 2 Weeks of Drug Exposure: A Retrospective Study","volume":"82","author":"Soria","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/ijd.13667","article-title":"Clinical Features of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Study of 25 Patients in Korea","volume":"56","author":"Lee","year":"2017","journal-title":"Int. J. Dermatol."},{"key":"ref_26","first-page":"35","article-title":"Antiviral Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Dyndrome: A Literature Review","volume":"8","author":"Sharifzadeh","year":"2020","journal-title":"J. Pharm. Care"},{"key":"ref_27","first-page":"e5015","article-title":"A Fatal Case of Vancomycin Associated Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome in a Septuagenarian","volume":"11","author":"Gangireddy","year":"2019","journal-title":"Cureus"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"518","DOI":"10.4306\/pi.2017.14.4.518","article-title":"Neosensitization to Multiple Drugs Following Valproate-Induced Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome","volume":"14","author":"Song","year":"2017","journal-title":"Psychiatry Investig."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Gentile, I., Talamo, M., and Borgia, G. (2010). Is the Drug-Induced Hypersensitivity Syndrome (DIHS) Due to Human Herpesvirus 6 Infection or to Allergy-Mediated Viral Reactivation? Report of a Case and Literature Review. BMC Infect. Dis., 10.","DOI":"10.1186\/1471-2334-10-49"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/jama.2014.7859","article-title":"Genetic Variants Associated with Phenytoin-Related Severe Cutaneous Adverse Reactions","volume":"312","author":"Chung","year":"2014","journal-title":"JAMA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/clpt.1991.3","article-title":"Prominence of Slow Acetylator Phenotype among Patients with Sulfonamide Hypersensitivity Reactions","volume":"49","author":"Rieder","year":"1991","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_32","first-page":"656","article-title":"Allopurinol-Induced DRESS Syndrome","volume":"7","author":"Markel","year":"2005","journal-title":"Isr. Med. Assoc. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/jcpt.12322","article-title":"Febuxostat-Associated Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)","volume":"40","author":"Chou","year":"2015","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_34","first-page":"269501","article-title":"DRESS Syndrome Due to Nevirapine Treated with Methylprednisolone","volume":"2013","author":"Gosuen","year":"2013","journal-title":"Case Rep. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMoa0706135","article-title":"HLA-B*5701 Screening for Hypersensitivity to Abacavir","volume":"358","author":"Mallal","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/jac\/dkn292","article-title":"Adverse Cutaneous Reactions Associated with the Newest Antiretroviral Drugs in Patients with Human Immunodeficiency Virus Infection","volume":"62","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jhep.2013.12.008","article-title":"First Case of Drug Rash Eosinophilia and Systemic Symptoms Due to Boceprevir","volume":"60","author":"Samain","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1001\/jamadermatol.2013.938","article-title":"Telaprevir-Related Dermatitis","volume":"149","author":"Roujeau","year":"2013","journal-title":"JAMA Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/annrheumdis-2021-220578","article-title":"Severe Delayed Hypersensitivity Reactions to IL-1 and IL-6 Inhibitors Link to Common HLA-DRB1*15 Alleles","volume":"81","author":"Saper","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4166\/kjg.2016.67.6.337","article-title":"A Case of Sorafenib-Induced DRESS Syndrome in Hepatocelluar Carcinoma","volume":"67","author":"Kim","year":"2016","journal-title":"Korean J. Gastroenterol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/ajd.12472","article-title":"Drug Reaction with Eosinophilia and Systemic Symptoms in Metastatic Basal Cell Carcinoma Treated with Vismodegib","volume":"58","author":"Thomas","year":"2017","journal-title":"Australas. J. Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/jdv.13443","article-title":"Profile of Vemurafenib-Induced Severe Skin Toxicities","volume":"30","author":"Peuvrel","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"124","DOI":"10.18176\/jiaci.0027","article-title":"Rivaroxaban-Induced Drug Reaction With Eosinophilia and Systemic Symptoms","volume":"26","author":"Radu","year":"2016","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10067-007-0772-1","article-title":"Hydroxychloroquine-Induced DRESS Syndrome","volume":"27","author":"Volpe","year":"2008","journal-title":"Clin. Rheumatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1365-2133.2007.07807.x","article-title":"The Diagnosis of a DRESS Syndrome Has Been Sufficiently Established on the Basis of Typical Clinical Features and Viral Reactivations","volume":"156","author":"Shiohara","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/1346-8138.15294","article-title":"Influence of Corticosteroid Therapy on Viral Reactivation in Drug-Induced Hypersensitivity Syndrome\/Drug Reaction with Eosinophilia and Systemic Symptoms","volume":"47","author":"Tohyama","year":"2020","journal-title":"J. Dermatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/ced.14362","article-title":"Monitoring of Human Herpesvirus 6 Infection in the Management of Drug Reaction with Eosinophilia and Systemic Symptoms","volume":"46","author":"Descamps","year":"2021","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1365-2133.2007.08167.x","article-title":"Association of Human Herpesvirus 6 Reactivation with the Flaring and Severity of Drug-Induced Hypersensitivity Syndrome","volume":"157","author":"Tohyama","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Miyagawa, F., and Asada, H. (2021). Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome\/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS\/DRESS). Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22042147"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s00198-015-3384-7","article-title":"A Fatal Case of DRESS Induced by Strontium Ranelate Associated with HHV-7 Reactivation","volume":"27","author":"Drago","year":"2016","journal-title":"Osteoporos. Int."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/bjd.13512","article-title":"Human Herpesvirus 6 Involvement in Paediatric Drug Hypersensitivity Syndrome","volume":"172","author":"Ahluwalia","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jaip.2016.11.027","article-title":"Virus Reactivation in Drug Reaction with Eosinophilia and Systemic Symptoms (Dress) Results from a Strong Drug-Specific Immune Response","volume":"5","author":"Roujeau","year":"2017","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Stirton, H., Shear, N.H., and Dodiuk-Gad, R.P. (2022). Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS)\/Drug-Induced Hypersensitivity Syndrome (DiHS)-Readdressing the DReSS. Biomedicines, 10.","DOI":"10.3390\/biomedicines10050999"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"46ra62","DOI":"10.1126\/scitranslmed.3001116","article-title":"Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A Multiorgan Antiviral T Cell Response","volume":"2","author":"Picard","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jaip.2022.02.004","article-title":"Drug-Induced Hypersensitivity Syndrome (DIHS)\/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis","volume":"10","author":"Hama","year":"2022","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.alit.2019.03.006","article-title":"Drug-Induced Hypersensitivity Syndrome (DiHS)\/Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): An Update in 2019","volume":"68","author":"Shiohara","year":"2019","journal-title":"Allergol. Int."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"5163129","DOI":"10.1155\/2018\/5163129","article-title":"Recent Advances in Drug-Induced Hypersensitivity Syndrome\/Drug Reaction with Eosinophilia and Systemic Symptoms","volume":"2018","author":"Watanabe","year":"2018","journal-title":"J. Immunol. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"586407","DOI":"10.3389\/fphar.2020.586407","article-title":"Viral Infections and Cutaneous Drug-Related Eruptions","volume":"11","author":"Anci","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jdcr.2015.04.017","article-title":"Detection of Cytomegalovirus in the Gastric Ulcer of a Patient with Drug-Induced Hypersensitivity Syndrome","volume":"1","author":"Kagoyama","year":"2015","journal-title":"JAAD Case Rep."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Ganeshanandan, L., and Lucas, M. (2021). Drug Reaction with Eosinophilia and Systemic Symptoms: A Complex Interplay between Drug, T Cells, and Herpesviridae. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22031127"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the Clinical Pattern of Cutaneous Side-Effects of Drugs with Systemic Symptoms: Does a DRESS Syndrome Really Exist?","volume":"156","author":"Kardaun","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2133.2006.07332.x","article-title":"Reactivation of Human Herpesvirus (HHV) Family Members Other than HHV-6 in Drug-Induced Hypersensitivity Syndrome","volume":"155","author":"Seishima","year":"2006","journal-title":"Br. J. Dermatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2133.2006.07238.x","article-title":"Several Herpesviruses Can Reactivate in a Severe Drug-Induced Multiorgan Reaction in the Same Sequential Order as in Graft-versus-Host Disease","volume":"155","author":"Kano","year":"2006","journal-title":"Br. J. Dermatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/archderm.134.9.1108","article-title":"Human Herpesvirus 6 Infection as a Risk Factor for the Development of Severe Drug-Induced Hypersensitivity Syndrome","volume":"134","author":"Suzuki","year":"1998","journal-title":"Arch. Dermatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/all.12410","article-title":"The Dynamics of Herpesvirus Reactivations during and after Severe Drug Eruptions: Their Relation to the Clinical Phenotype and Therapeutic Outcome","volume":"69","author":"Ishida","year":"2014","journal-title":"Allergy"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/all.12602","article-title":"Human Herpes Virus Reactivations and Dynamic Cytokine Profiles in Patients with Cutaneous Adverse Drug Reactions\u2014A Prospective Comparative Study","volume":"70","author":"Chen","year":"2015","journal-title":"Allergy"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"723062","DOI":"10.1155\/2012\/723062","article-title":"The Link between Hypersensitivity Syndrome Reaction Development and Human Herpes Virus-6 Reactivation","volume":"2012","author":"Pritchett","year":"2012","journal-title":"Int. J. Hepatol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Shiohara, T., Takahashi, R., and Kano, Y. (2007). Drug-Induced Hypersensitivity Syndrome and Viral Reactivation. Drug Hypersensit., 251\u2013266.","DOI":"10.1159\/000104205"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jaad.2005.03.057","article-title":"Fulminant Type 1 Diabetes Mellitus Caused by Drug Hypersensitivity Syndrome with Human Herpesvirus 6 Infection","volume":"54","author":"Chiou","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Lee, E.S., Kiuchi, Y., Inomata, N., and Sueki, H. (2022). Increased Expression of Human Herpes Virus 6 Receptor CD134\/OX40 in Skin Lesions of Patients with Drug-Induced Hypersensitivity Syndrome\/Drug Reaction with Eosinophilia and Systemic Symptoms. J. Dermatol.","DOI":"10.1111\/1346-8138.16575"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1542\/peds.2007-2838","article-title":"Chromosomal Integration of Human Herpesvirus 6 Is the Major Mode of Congenital Human Herpesvirus 6 Infection","volume":"122","author":"Hall","year":"2008","journal-title":"Pediatrics"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1365-2133.2007.08382.x","article-title":"Chromosomal Integration of Human Herpesvirus 6 DNA in Anticonvulsant Hypersensitivity Syndrome","volume":"158","author":"Watanabe","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jmii.2014.06.012","article-title":"Drug Reaction with Eosinophilia and Systemic Symptoms during Primary Epstein-Barr Virus Infection","volume":"48","author":"Nanishi","year":"2015","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1111\/j.1528-1167.2008.01660.x","article-title":"Carbamazepine-Induced DRESS and HHV6 Primary Infection: The Importance of Skin Tests","volume":"49","author":"Aouam","year":"2008","journal-title":"Epilepsia"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2340\/00015555-2791","article-title":"Predominant Contribution of CD4 T Cells to Human Herpesvirus 6 (HHV-6) Load in the Peripheral Blood of Patients with Drug-Induced Hypersensitivity Syndrome and Persistent HHV-6 Infection","volume":"98","author":"Miyagawa","year":"2018","journal-title":"Acta Derm. Venereol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e417","DOI":"10.1111\/1346-8138.15548","article-title":"Parallel Changes in Serum Thymus and Activation-Regulated Chemokine Levels in Response to Flare-Ups in Drug-Induced Hypersensitivity Syndrome","volume":"47","author":"Kanatani","year":"2020","journal-title":"J. Dermatol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1128\/JCM.00097-13","article-title":"Evidence for Reactivation of Human Herpesvirus 6 in Generalized Lymphadenopathy in a Patient with Drug-Induced Hypersensitivity Syndrome","volume":"51","author":"Saraya","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2340\/00015555-2149","article-title":"Involvement of Human Herpesvirus 6 Infection in Renal Dysfunction Associated with DIHS\/DRESS","volume":"96","author":"Miyashita","year":"2016","journal-title":"Acta Derm. Venereol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"612","DOI":"10.2340\/00015555-2925","article-title":"Up-Regulation of Human Herpesvirus 6B-Derived MicroRNAs in the Serum of Patients with Drug-Induced Hypersensitivity Syndrome\/Drug Reaction with Eosinophilia and Systemic Symptoms","volume":"98","author":"Miyashita","year":"2018","journal-title":"Acta Derm. Venereol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2332\/allergolint.55.1","article-title":"Drug-Induced Hypersensitivity Syndrome(DIHS): A Reaction Induced by a Complex Interplay among Herpesviruses and Antiviral and Antidrug Immune Responses","volume":"55","author":"Shiohara","year":"2006","journal-title":"Allergol. Int."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1684\/ejd.2017.3117","article-title":"Herpes Simplex Virus Reactivation: Is It Common or Rare in Drug-Induced Hypersensitivity Syndrome\/Drug Reaction with Eosinophilia and Systemic Symptoms?","volume":"27","author":"Kurata","year":"2017","journal-title":"Eur. J. Dermatol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2340\/00015555-1993","article-title":"Drug-Induced Hypersensitivity Syndrome in Association with Varicella","volume":"95","author":"Tsutsumi","year":"2015","journal-title":"Acta Derm. Venereol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"112","DOI":"10.11622\/smedj.2018016","article-title":"Cytomegalovirus (CMV) Hepatitis: An Uncommon Complication of CMV Reactivation in Drug Reaction with Eosinophilia and Systemic Symptoms","volume":"59","author":"Wong","year":"2018","journal-title":"Singap. Med. J."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"ofx029","DOI":"10.1093\/ofid\/ofx029","article-title":"Association Between Cytomegalovirus Reactivation and Clinical Outcomes in Immunocompetent Critically Ill Patients: A Systematic Review and Meta-Analysis","volume":"4","author":"Lachance","year":"2017","journal-title":"Open Forum Infect. Dis."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fmed.2020.00188","article-title":"Cytomegalovirus: A Troll in the ICU? Overview of the Literature and Perspectives for the Future","volume":"7","author":"Schildermans","year":"2020","journal-title":"Front. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13613-020-00793-2","article-title":"Preemptive Ganciclovir for Mechanically Ventilated Patients with Cytomegalovirus Reactivation","volume":"11","author":"Papazian","year":"2021","journal-title":"Ann. Intensive Care"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1001\/jama.2017.10569","article-title":"Effect of Ganciclovir on IL-6 Levels Among Cytomegalovirus-Seropositive Adults With Critical Illness: A Randomized Clinical Trial","volume":"318","author":"Limaye","year":"2017","journal-title":"JAMA"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/jamainternmed.2017.0895","article-title":"Safety and Efficacy of Antiviral Therapy for Prevention of Cytomegalovirus Reactivation in Immunocompetent Critically Ill Patients: A Randomized Clinical Trial","volume":"177","author":"Cowley","year":"2017","journal-title":"JAMA Intern. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e700","DOI":"10.1111\/jdv.16838","article-title":"Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome in a Patient with COVID-19","volume":"34","author":"Herman","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e13499","DOI":"10.1111\/dth.13499","article-title":"Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome to Hydroxychloroquine, an Old Drug in the Spotlight in the COVID-19 Era","volume":"33","author":"Grandolfo","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"816","DOI":"10.5114\/ada.2021.109586","article-title":"Sustained Drug-Related Reaction with Eosinophilia and Systemic Symptoms (DRESS) Triggered by Low Molecular Weight Heparins in COVID-19: Management and Precision Diagnosis","volume":"39","author":"Minenna","year":"2022","journal-title":"Postepy Dermatol. Alergol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00403-020-02171-1","article-title":"Follow-up of Skin Lesions during COVID-19: A Description of a DRESS Case","volume":"313","author":"Brunasso","year":"2021","journal-title":"Arch. Dermatol. Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"e241418","DOI":"10.1136\/bcr-2020-241418","article-title":"Life-Threatening DRESS Syndrome with Kidney Damage Following Severe COVID-19 in a Patient with Down Syndrome","volume":"14","author":"Mata","year":"2021","journal-title":"BMJ Case Rep."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/cod.13657","article-title":"First Case of DRESS Syndrome Caused by Hydroxychloroquine with a Positive Patch Test","volume":"84","year":"2021","journal-title":"Contact Dermat."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/ijd.15316","article-title":"Detection of SARS-CoV-2 in a Case of DRESS by Sulfasalazine: Could There Be a Relationship with Clinical Importance?","volume":"60","author":"Balconi","year":"2021","journal-title":"Int. J. Dermatol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jaip.2020.09.039","article-title":"Benralizumab for Severe DRESS in Two COVID-19 Patients","volume":"9","author":"Steiger","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Cruz, V.B., J\u00fanior, L.F.F.F., Kobal, C.R., and da Silva, N.A. (2022). Does Sensitization by SARS-CoV-2 Immune Complexes Trigger DRESS Syndrome?. Braz. J. Infect. Dis., 26.","DOI":"10.1016\/j.bjid.2022.102337"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1016\/j.jaip.2021.06.047","article-title":"Benralizumab: A Potential Tailored Treatment for Life-Threatening DRESS in the COVID-19 Era","volume":"9","author":"Mesli","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/bjd.21706","article-title":"Drug Reaction with Eosinophilia and Systemic Symptoms in Patients Hospitalized with COVID-19: A Case Series from a Large US Healthcare System","volume":"187","author":"Cucka","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.annder.2008.10.007","article-title":"Hydroxychloroquine and Dress","volume":"135","author":"Schmutz","year":"2008","journal-title":"Ann. Dermatol. Venereol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/all.14983","article-title":"Cutaneous and Systemic Hyperinflammation Drives Maculopapular Drug Exanthema in Severely Ill COVID-19 Patients","volume":"77","author":"Mitamura","year":"2022","journal-title":"Allergy"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1016\/j.jaip.2021.06.048","article-title":"Reply to \u201cBenralizumab: A Potential Tailored Treatment for Life-Threatening DRESS in the COVID-19 Era\u201d","volume":"9","author":"Lang","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Brooks, B., Tancredi, C., Song, Y., Mogus, A.T., Huang, M.L.W., Zhu, H., Phan, T.L., Zhu, H., Kadl, A., and Woodfolk, J. (2022). Epstein-Barr Virus and Human Herpesvirus-6 Reactivation in Acute COVID-19 Patients. Viruses, 14.","DOI":"10.3390\/v14091872"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.idnow.2021.01.005","article-title":"High Incidence of Epstein-Barr Virus, Cytomegalovirus, and Human-Herpes Virus-6 Reactivations in Critically Ill Patients with COVID-19","volume":"51","author":"Simonnet","year":"2021","journal-title":"Infect. Dis. Now"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1177\/08850666211053990","article-title":"Reactivation of EBV and CMV in Severe COVID-19-Epiphenomena or Trigger of Hyperinflammation in Need of Treatment? A Large Case Series of Critically Ill Patients","volume":"37","author":"Naendrup","year":"2022","journal-title":"J. Intensive Care Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1507\/endocrj.EJ17-0249","article-title":"A Case Report of Fulminant Type 1 Diabetes Mellitus Associated with Drug-Induced Hypersensitivity Syndrome in an Elderly Patient with Coxsackie B4 Virus Infection and Human Leukocyte Antigen-A24 Haplotype","volume":"65","author":"Takeno","year":"2018","journal-title":"Endocr. J."},{"key":"ref_107","first-page":"277","article-title":"DRESS Syndrome Associated with Influenza Virus","volume":"32","author":"Girijala","year":"2019","journal-title":"Proc. (Bayl. Univ. Med. Cent.)"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"e244063","DOI":"10.1136\/bcr-2021-244063","article-title":"Sulfasalazine-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) with Concomitant Acute Chikungunya Virus Infection: Possible Role of New Viral Trigger","volume":"14","author":"Sil","year":"2021","journal-title":"BMJ Case Rep."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s15010-020-01472-x","article-title":"Chik Sign in Chikungunya Fever","volume":"49","author":"Panigrahi","year":"2021","journal-title":"Infection"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/postgradmedj-2020-137504","article-title":"Post-Chikungunya Hyperpigmentation","volume":"97","author":"Sil","year":"2021","journal-title":"Postgrad. Med. J."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1590\/abd1806-4841.20165805","article-title":"Hyperpigmentation and Chikungunya Fever","volume":"91","author":"Srivastava","year":"2016","journal-title":"An. Bras. Dermatol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.jid.2019.11.020","article-title":"Analysis of Skin-Resident Memory T Cells Following Drug Hypersensitivity Reactions","volume":"140","author":"Trubiano","year":"2020","journal-title":"J. Investig. Dermatol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/qjmed\/hcaa329","article-title":"Chik Sign: Post-Chikungunya Hyperpigmentation","volume":"114","author":"Chakraborty","year":"2021","journal-title":"QJM"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/cid\/cix096","article-title":"Association of the HLA-B*53:01 Allele With Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome During Treatment of HIV Infection With Raltegravir","volume":"64","author":"Thomas","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"401","DOI":"10.4103\/0253-7613.114993","article-title":"Nevirapine-Induced Rash with Eosinophilia and Systemic Symptoms (DRESS)","volume":"45","author":"Gill","year":"2013","journal-title":"Indian J. Pharmacol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"ofw130","DOI":"10.1093\/ofid\/ofw130","article-title":"Therapeutic Trial of Rifabutin After Rifampicin-Associated DRESS Syndrome in Tuberculosis-Human Immunodeficiency Virus Coinfected Patients","volume":"3","author":"Lehloenya","year":"2016","journal-title":"Open Forum Infect. Dis."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2230.2010.03967.x","article-title":"Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A Clinical Update and Review of Current Thinking","volume":"36","author":"Walsh","year":"2011","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1365-2133.2003.05368.x","article-title":"Carbamazepine-Induced Hypersensitivity Syndrome Associated with Transient Hypogammaglobulinaemia and Reactivation of Human Herpesvirus 6 Infection Demonstrated by Real-Time Quantitative Polymerase Chain Reaction","volume":"149","author":"Aihara","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/archderm.140.2.183","article-title":"Association between Anticonvulsant Hypersensitivity Syndrome and Human Herpesvirus 6 Reactivation and Hypogammaglobulinemia","volume":"140","author":"Kano","year":"2004","journal-title":"Arch. Dermatol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"adv00102","DOI":"10.2340\/00015555-3465","article-title":"Correlation Between Expression of CD134, a Human Herpesvirus 6 Cellular Receptor, on CD4+ T Cells and Th2-Type Immune Responses in Drug-Induced Hypersensitivity Syndrome\/Drug Reaction with Eosinophilia and Systemic Symptoms","volume":"100","author":"Miyagawa","year":"2020","journal-title":"Acta Derm. Venereol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jdcr.2018.11.017","article-title":"Nivolumab-Associated DRESS Syndrome: A Case Report","volume":"5","author":"Lu","year":"2019","journal-title":"JAAD Case Rep."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"e002879","DOI":"10.1136\/jitc-2021-002879","article-title":"Nivolumab-Associated DRESS in a Genetic Susceptible Individual","volume":"9","author":"Ai","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jaci.2010.06.004","article-title":"Fluctuation of Blood and Skin Plasmacytoid Dendritic Cells in Drug-Induced Hypersensitivity Syndrome","volume":"126","author":"Sugita","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijid.2020.08.078","article-title":"Predictive Biomarkers for Cytomegalovirus Reactivation before and after Immunosuppressive Therapy: A Single-Institution Retrospective Long-Term Analysis of Patients with Drug-Induced Hypersensitivity Syndrome (DiHS)\/Drug Reaction with Eosinophilia and Systemic Syndrome (DRESS)","volume":"100","author":"Mizukawa","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jaci.2013.02.045","article-title":"Activation of Carbamazepine-Responsive T-Cell Clones with Metabolically Inert Halogenated Derivatives","volume":"132","author":"Farrell","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/bjd.14839","article-title":"Drug-Specific CD4+ T-Cell Immune Responses Are Responsible for Antituberculosis Drug-Induced Maculopapular Exanthema and Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome","volume":"176","author":"Ye","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/cpt.1493","article-title":"Shared Genetic Risk Factors Across Carbamazepine-Induced Hypersensitivity Reactions","volume":"106","author":"Nicoletti","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.jaci.2010.11.046","article-title":"Drug Hypersensitivity: Pharmacogenetics and Clinical Syndromes","volume":"127","author":"Phillips","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jaci.2019.01.045","article-title":"HLA-A*32:01 Is Strongly Associated with Vancomycin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms","volume":"144","author":"Konvinse","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"6431694","DOI":"10.1155\/2018\/6431694","article-title":"An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity","volume":"2018","author":"Chen","year":"2018","journal-title":"J. Immunol. Res."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.phrs.2016.11.027","article-title":"Significant HLA Class I Type Associations with Aromatic Antiepileptic Drug (AED)-Induced SJS\/TEN Are Different from Those Found for the Same AED-Induced DRESS in the Spanish Population","volume":"115","author":"Tong","year":"2017","journal-title":"Pharmacol. Res."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jdermsci.2013.10.003","article-title":"Genotype-Phenotype Association between HLA and Carbamazepine-Induced Hypersensitivity Reactions: Strength and Clinical Correlations","volume":"73","author":"Hsiao","year":"2014","journal-title":"J. Dermatol. Sci."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.seizure.2017.10.018","article-title":"HLA-A*31:01 and Carbamazepine-Induced DRESS Syndrom in a Sample of North African Population","volume":"53","author":"Ksouda","year":"2017","journal-title":"Seizure"},{"key":"ref_134","first-page":"281","article-title":"HLA-A*31:01 and Different Types of Carbamazepine-Induced Severe Cutaneous Adverse Reactions: An International Study and Meta-Analysis","volume":"14","author":"Genin","year":"2014","journal-title":"Pharm. J."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.anai.2017.02.011","article-title":"HLA-A*31:01 and Lamotrigine-Induced Severe Cutaneous Adverse Drug Reactions in a Korean Population","volume":"118","author":"Kim","year":"2017","journal-title":"Ann. Allergy Asthma. Immunol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/FPC.0b013e32834282b8","article-title":"Positive and Negative Associations of HLA Class i Alleles with Allopurinol-Induced SCARs in Koreans","volume":"21","author":"Kang","year":"2011","journal-title":"Pharm. Genom."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.jid.2018.02.004","article-title":"The Function of HLA-B*13:01 Involved in the Pathomechanism of Dapsone-Induced Severe Cutaneous Adverse Reactions","volume":"138","author":"Chen","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1056\/NEJMoa1213096","article-title":"HLA-B*13:01 and the Dapsone Hypersensitivity Syndrome","volume":"369","author":"Zhang","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.2217\/pgs.14.69","article-title":"HLA-B\u221713:01 Is Associated with Salazosulfapyridine-Induced Drug Rash with Eosinophilia and Systemic Symptoms in Chinese Han Population","volume":"15","author":"Yang","year":"2014","journal-title":"Pharmacogenomics"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.jaci.2020.08.003","article-title":"Whole Genome Sequencing Identifies Genetic Variants Associated with Co-Trimoxazole Hypersensitivity in Asians","volume":"147","author":"Wang","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/FPC.0000000000000211","article-title":"Associations between HLA Class I and Cytochrome P450 2C9 Genetic Polymorphisms and Phenytoin-Related Severe Cutaneous Adverse Reactions in a Thai Population","volume":"26","author":"Tassaneeyakul","year":"2016","journal-title":"Pharm. Genom."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1111\/bcp.14025","article-title":"High and Variable Population Prevalence of HLA-B*56:02 in Indigenous Australians and Relation to Phenytoin-Associated Drug Reaction with Eosinophilia and Systemic Symptoms","volume":"85","author":"Somogyi","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2780272","DOI":"10.1155\/2018\/2780272","article-title":"Association between HLA-B Alleles and Carbamazepine-Induced Maculopapular Exanthema and Severe Cutaneous Reactions in Thai Patients","volume":"2018","author":"Sukasem","year":"2018","journal-title":"J. Immunol. Res."},{"key":"ref_144","first-page":"170","article-title":"Association of HLA-B*15:13 and HLA-B*15:02 with Phenytoin-Induced Severe Cutaneous Adverse Reactions in a Malay Population","volume":"17","author":"Chang","year":"2017","journal-title":"Pharm. J."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/cid\/cit021","article-title":"Association of Human Leukocyte Antigen Alleles and Nevirapine Hypersensitivity in a Malawian HIV-Infected Population","volume":"56","author":"Carr","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1002\/eji.202149179","article-title":"HLA-DRB1*15:01 Is a Co-Receptor for Epstein\u2013Barr Virus, Linking Genetic and Environmental Risk Factors for Multiple Sclerosis","volume":"51","author":"Menegatti","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3389\/fphar.2020.567048","article-title":"Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines","volume":"11","author":"Manson","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"597761","DOI":"10.3389\/fimmu.2021.597761","article-title":"The Roles of Immunoregulatory Networks in Severe Drug Hypersensitivity","volume":"12","author":"Hsu","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_149","unstructured":"(2022, December 16). Hospital Discharges and Length of Stay Statistics\u2014Statistics Explained. Available online: https:\/\/ec.europa.eu\/eurostat\/statistics-explained\/index.php?title=Hospital_discharges_and_length_of_stay_statistics&oldid=574861#Hospital_discharges."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10096-010-1081-1","article-title":"Correlation between Antimicrobial Consumption and Resistance among Staphylococcus Aureus and Enterococci Causing Healthcare-Associated Infections at a University Hospital in Taiwan from 2000 to 2009","volume":"30","author":"Lai","year":"2011","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_151","unstructured":"(2022, December 16). Antimicrobial Resistance Surveillance in Europe 2022\u20132020 Data. Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/antimicrobial-resistance-surveillance-europe-2022-2020-data."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Junior, M.S., Correa, L., Marra, A.R., Camargo, L.F.A., and Pereira, C.A.P. (2007). Analysis of Vancomycin Use and Associated Risk Factors in a University Teaching Hospital: A Prospective Cohort Study. BMC Infect. Dis., 7.","DOI":"10.1186\/1471-2334-7-88"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000453265","article-title":"Classification of Drug Hypersensitivity into Allergic, p-i, and Pseudo-Allergic Forms","volume":"171","author":"Pichler","year":"2016","journal-title":"Int. Arch. Allergy Immunol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/all.12008","article-title":"Human Leukocyte Antigens (HLA) Associated Drug Hypersensitivity: Consequences of Drug Binding to HLA","volume":"67","author":"Yun","year":"2012","journal-title":"Allergy"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.1073\/pnas.1207934109","article-title":"Drug Hypersensitivity Caused by Alteration of the MHC-Presented Self-Peptide Repertoire","volume":"109","author":"Ostrov","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2332\/allergolint.55.17","article-title":"Pharmacological Interaction of Drugs with Immune Receptors: The p-i Concept","volume":"55","author":"Pichler","year":"2006","journal-title":"Allergol. Int."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.jaci.2011.12.990","article-title":"Direct Interaction between HLA-B and Carbamazepine Activates T Cells in Patients with Stevens-Johnson Syndrome","volume":"129","author":"Wei","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/all.13765","article-title":"Immune Pathomechanism and Classification of Drug Hypersensitivity","volume":"74","author":"Pichler","year":"2019","journal-title":"Allergy"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2230.2008.02823.x","article-title":"Drug Rash with Eosinophilia and Systemic Symptoms and Graft-versus-Host Disease Developing Sequentially in a Patient","volume":"34","author":"Natkunarajah","year":"2009","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jaci.2020.04.056","article-title":"Cross-Reactivity between Vancomycin, Teicoplanin, and Telavancin in Patients with HLA-A\u221732:01-Positive Vancomycin-Induced DRESS Sharing an HLA Class II Haplotype","volume":"147","author":"Nakkam","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1111\/all.13418","article-title":"Identification of T-Cell Epitopes from Benzylpenicillin Conjugated to Human Serum Albumin and Implication in Penicillin Allergy","volume":"73","author":"Azoury","year":"2018","journal-title":"Allergy"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1016\/j.jaip.2021.04.013","article-title":"Considerations for Cross-Reactivity between Vancomycin and Other Glycopeptides","volume":"9","author":"Nakkam","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/art.10263","article-title":"Epitope Spreading in Systemic Lupus Erythematosus: Identification of Triggering Peptide Sequences","volume":"46","author":"Monneaux","year":"2002","journal-title":"Arthr. Rheum"},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Lucas, A., Lucas, M., Strhyn, A., Keane, N.M., McKinnon, E., Pavlos, R., Moran, E.M., Meyer-Pannwitt, V., Gaudieri, S., and D\u2019Orsogna, L. (2015). Abacavir-Reactive Memory T Cells Are Present in Drug Na\u00efve Individuals. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0117160"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1346-8138.2005.tb00762.x","article-title":"Drug-Induced Hypersensitivity Syndrome Due to Mexiletine Associated with Human Herpes Virus 6 and Cytomegalovirus Reactivation","volume":"32","author":"Sekiguchi","year":"2005","journal-title":"J. Dermatol."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Yerly, D., Pompeu, Y.A., Schutte, R.J., Eriksson, K.K., Strhyn, A., Bracey, A.W., Buus, S., and Ostrov, D.A. (2017). Structural Elements Recognized by Abacavir-Induced T Cells. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18071464"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jaci.2019.05.009","article-title":"Virus-Specific T-Cell Clonotypes Might Contribute to Drug Hypersensitivity Reactions through Heterologous Immunity","volume":"144","author":"Almeida","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"9913","DOI":"10.1038\/srep09913","article-title":"Association of CD8(+) T Lymphocyte Repertoire Spreading with the Severity of DRESS Syndrome","volume":"5","author":"Niu","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1038\/jid.2015.165","article-title":"Oxypurinol-Specific T Cells Possess Preferential TCR Clonotypes and Express Granulysin in Allopurinol-Induced Severe Cutaneous Adverse Reactions","volume":"135","author":"Chung","year":"2015","journal-title":"J. Investig. Dermatol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/JTO.0000000000000364","article-title":"Increase in Activated Treg in TIL in Lung Cancer and in Vitro Depletion of Treg by ADCC Using an Antihuman CCR4 MAb (KM2760)","volume":"10","author":"Kurose","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/bjd.12948","article-title":"Elevated Serum Thymus and Activation-Regulated Chemokine (TARC\/CCL17) Relates to Reactivation of Human Herpesvirus 6 in Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)\/Drug-Induced Hypersensitivity Syndrome (DIHS)","volume":"171","author":"Ogawa","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/cea.13252","article-title":"Monocytes Are Involved in the Balance between Regulatory T Cells and Th17 Cells in Severe Drug Eruptions","volume":"48","author":"Ushigome","year":"2018","journal-title":"Clin. Exp. Allergy"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"8071","DOI":"10.4049\/jimmunol.0804002","article-title":"Defective Regulatory T Cells in Patients with Severe Drug Eruptions: Timing of the Dysfunction Is Associated with the Pathological Phenotype and Outcome","volume":"182","author":"Takahashi","year":"2009","journal-title":"J. Immunol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clicom.2022.01.002","article-title":"Real-Life Efficacy and Safety of Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis","volume":"2","author":"Ramirez","year":"2022","journal-title":"Clin. Immunol. Commun."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/088282403322017857","article-title":"Rhinovirus and Asthma","volume":"16","author":"Yamaya","year":"2003","journal-title":"Viral Immunol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.jaci.2018.09.033","article-title":"Assessment of the Long-Term Safety of Mepolizumab and Durability of Clinical Response in Patients with Severe Eosinophilic Asthma","volume":"143","author":"Khatri","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1111\/all.13802","article-title":"Eosinophils Capture Viruses, a Capacity That Is Defective in Asthma","volume":"74","author":"Bal","year":"2019","journal-title":"Allergy"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"9095275","DOI":"10.1155\/2018\/9095275","article-title":"Eosinophils from Physiology to Disease: A Comprehensive Review","volume":"2018","author":"Ramirez","year":"2018","journal-title":"BioMed Res. Int."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.jid.2018.10.048","article-title":"Increased Type 2 Innate Lymphoid Cells in Patients with Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome","volume":"139","author":"Tsai","year":"2019","journal-title":"J. Investig. Dermatol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1111\/all.12311","article-title":"CD8(+) T Cells Producing IL-3 and IL-5 in Non-IgE-Mediated Eosinophilic Diseases","volume":"68","author":"Stoeckle","year":"2013","journal-title":"Allergy"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1038\/s41467-019-12515-9","article-title":"Genome-Wide Association Study of Eosinophilic Granulomatosis with Polyangiitis Reveals Genomic Loci Stratified by ANCA Status","volume":"10","author":"Lyons","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrd3838","article-title":"Targeting Eosinophils in Allergy, Inflammation and Beyond","volume":"12","author":"Fulkerson","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"163","DOI":"10.12659\/AJCR.907464","article-title":"Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Secondary to Furosemide: Case Report and Review of Literature","volume":"19","author":"James","year":"2018","journal-title":"Am. J. Case Rep."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.alit.2016.04.001","article-title":"Drug-Induced Hypersensitivity Syndrome\/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS\/DRESS): 11 Years Retrospective Study in Thailand","volume":"65","author":"Hiransuthikul","year":"2016","journal-title":"Allergol. Int."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/21548331.2018.1451205","article-title":"DRESS Syndrome: A Detailed Insight","volume":"46","author":"Behera","year":"2018","journal-title":"Hosp. Pract. (1995)"},{"key":"ref_186","first-page":"1159","article-title":"Abnormal Erythrocyte Morphology in Drug Reaction with Eosinophilia and Systemic Symptoms","volume":"80","author":"Anderson","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1365-2133.2006.07284.x","article-title":"Variability in the Clinical Pattern of Cutaneous Side-Effects of Drugs with Systemic Symptoms: Does a DRESS Syndrome Really Exist?","volume":"155","author":"Dereure","year":"2006","journal-title":"Br. J. Dermatol."},{"key":"ref_188","first-page":"31","article-title":"Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome","volume":"6","author":"Choudhary","year":"2013","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/j.1368-5031.2005.00550.x","article-title":"Carbamazepine-Induced Acute Liver Failure as Part of the DRESS Syndrome","volume":"59","author":"Syn","year":"2005","journal-title":"Int. J. Clin. Pract."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4322\/acr.2012.029","article-title":"Hepatic Necrosis Associated with Drug-Induced Hypersensitivity Syndrome","volume":"2","author":"Maragno","year":"2012","journal-title":"Autops. Case Rep."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1002\/ccr3.3218","article-title":"Trimethoprim-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Associated with Reactivation of Human Herpes Virus-6 (HHV-6) Leading to Acute Liver Failure","volume":"8","author":"Subhani","year":"2020","journal-title":"Clin. Case Rep."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jaad.2013.03.024","article-title":"Characteristics of Liver Injury in Drug-Induced Systemic Hypersensitivity Reactions","volume":"69","author":"Lee","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"e928587","DOI":"10.12659\/AJCR.928587","article-title":"A 51-Year-Old Woman with Drug-Induced Hypersensitivity Syndrome Associated with Carbamazepine, Reactivation of Human Herpesvirus 6, and Acute Liver Failure: A Case Report","volume":"22","author":"Miyasaka","year":"2021","journal-title":"Am. J. Case Rep."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"693.e1","DOI":"10.1016\/j.jaad.2013.01.033","article-title":"DRESS Syndrome: Part I. Clinical Perspectives","volume":"68","author":"Husain","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/ccr3.3680","article-title":"Chronic Persistent HHV-6B Infection after Sulfasalazine-Induced DRESS with Demonstration of HHV-6 Encoded Small Noncoding RNAs (SncRNAs) in Crohn\u2019s-like Colitis: Case Report","volume":"9","author":"Descamps","year":"2020","journal-title":"Clin. Case Rep."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/archdermatol.2009.195","article-title":"Cytomegalovirus Disease during Severe Drug Eruptions: Report of 2 Cases and Retrospective Study of 18 Patients with Drug-Induced Hypersensitivity Syndrome","volume":"145","author":"Asano","year":"2009","journal-title":"Arch. Dermatol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2133.2011.10293.x","article-title":"Drug Reaction with Eosinophilia and Systemic Symptoms and Severe Involvement of Digestive Tract: Description of Two Cases","volume":"165","author":"Charachon","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1046\/j.1365-2133.2003.05330.x","article-title":"Drug-Induced Hypersensitivity Syndrome Associated with Epstein\u2013Barr Virus Infection","volume":"148","author":"Descamps","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/jama.285.9.1153","article-title":"Rapid Loss of Insulin Secretion in a Patient with Fulminant Type 1 Diabetes Mellitus and Carbamazepine Hypersensitivity Syndrome","volume":"285","author":"Sekine","year":"2001","journal-title":"JAMA"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.mcna.2010.03.004","article-title":"Visceral Involvements and Long-Term Sequelae in Drug-Induced Hypersensitivity Syndrome","volume":"94","author":"Kano","year":"2010","journal-title":"Med. Clin. N. Am."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.iac.2009.04.007","article-title":"The Variable Clinical Picture of Drug-Induced Hypersensitivity Syndrome\/Drug Rash with Eosinophilia and Systemic Symptoms in Relation to the Eliciting Drug","volume":"29","author":"Kano","year":"2009","journal-title":"Immunol. Allergy Clin. N. Am."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"316","DOI":"10.5414\/CN108966","article-title":"Acute Kidney Injury in Allopurinol-Induced DRESS Syndrome: A Case Report of Concurrent Tubulointerstitial Nephritis and Kidney-Limited Necrotizing Vasculitis","volume":"87","author":"Esposito","year":"2017","journal-title":"Clin. Nephrol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.2169\/internalmedicine.55.6287","article-title":"Reactivation of Human Herpes Virus-6 in the Renal Tissue of a Patient with Drug-Induced Hypersensitivity Syndrome\/Drug Rash with Eosinophilia and Systemic Symptoms (DIHS\/DRESS)","volume":"55","author":"Hagiya","year":"2016","journal-title":"Intern. Med."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1016\/j.jaad.2010.11.057","article-title":"A Review of DRESS-Associated Myocarditis","volume":"66","author":"Bourgeois","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"7863815","DOI":"10.1155\/2019\/7863815","article-title":"Pulmonary Manifestations of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Systematic Review","volume":"2019","author":"Taweesedt","year":"2019","journal-title":"BioMed Res. Int."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/00015550310007481","article-title":"Human Herpes Virus 6 Encephalitis in Allopurinol-Induced Hypersensitivity Syndrome","volume":"83","author":"Masaki","year":"2003","journal-title":"Acta Derm. Venereol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.2169\/internalmedicine.55.6035","article-title":"Autoimmune Limbic Encephalitis and Syndrome of Inappropriate Antidiuretic Hormone Secretion Associated with Lamotrigine-Induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Syndrome","volume":"55","author":"Ozisik","year":"2016","journal-title":"Intern. Med."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"bcr-2017222540","DOI":"10.1136\/bcr-2017-222540","article-title":"Sensory Ganglionopathy Associated with Drug-Induced Hypersensitivity Syndrome Caused by Mexiletine","volume":"2018","author":"Yokote","year":"2018","journal-title":"BMJ Case Rep."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3389\/fendo.2019.00474","article-title":"Fulminant Type 1 Diabetes Mellitus Caused by Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): A Case Report and Review of the Literature","volume":"10","author":"Zhu","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jid.2021.11.008","article-title":"Risk of Progression to Autoimmune Disease in Severe Drug Eruption: Risk Factors and the Factor-Guided Stratification","volume":"142","author":"Mizukawa","year":"2022","journal-title":"J. Investig. Dermatol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.mcna.2021.04.001","article-title":"Recognition and Management of Severe Cutaneous Adverse Drug Reactions (Including Drug Reaction with Eosinophilia and Systemic Symptoms, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis)","volume":"105","author":"Owen","year":"2021","journal-title":"Med. Clin. N. Am."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jaad.2020.03.095","article-title":"Viral Reactivation in Hospitalized Patients with Drug Reaction with Eosinophilia and Systemic Symptoms: A Retrospective Study from a Tertiary Medical Center in the United States","volume":"83","author":"Trinidad","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/S0140-6736(22)00464-0","article-title":"Acute Onset of Fever, Eosinophilia, Rash, Acute Kidney Injury, and a Positive Monospot Test in a Patient on Lamotrigine: DRESS Syndrome","volume":"399","author":"Abdelnabi","year":"2022","journal-title":"Lancet"},{"key":"ref_214","first-page":"3","article-title":"Cardiac Involvement in DRESS Syndrome","volume":"35","author":"Thongsri","year":"2017","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/cod.14090","article-title":"Patch Testing in Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A Literature Review","volume":"86","year":"2022","journal-title":"Contact Dermat."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1398-9995.2004.00547.x","article-title":"The Lymphocyte Transformation Test in the Diagnosis of Drug Hypersensitivity","volume":"59","author":"Pichler","year":"2004","journal-title":"Allergy"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/bjd.12783","article-title":"Histopathological Analysis and Clinical Correlation of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)","volume":"170","author":"Chi","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1001\/archderm.1987.01660330071012","article-title":"Toxic Epidermal Necrolysis. Clinical Findings and Prognosis Factors in 87 Patients","volume":"123","author":"Revuz","year":"1987","journal-title":"Arch. Dermatol."},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Ye, L.-P., Zhang, C., and Zhu, Q.-X. (2016). The Effect of Intravenous Immunoglobulin Combined with Corticosteroid on the Progression of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Meta-Analysis. PloS ONE, 11.","DOI":"10.1371\/journal.pone.0167120"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1365-2230.2009.03718.x","article-title":"Stevens\u2013Johnson Syndrome and Toxic Epidermal Necrolysis Due to Anticonvulsants Share Certain Clinical and Laboratory Features with Drug-Induced Hypersensitivity Syndrome, despite Differences in Cutaneous Presentations","volume":"35","author":"Teraki","year":"2010","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.iac.2016.08.006","article-title":"Cutaneous Manifestation of Drug Allergy and Hypersensitivity","volume":"37","author":"Spiewak","year":"2017","journal-title":"Immunol. Allergy Clin. N. Am."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.mcna.2010.04.001","article-title":"Delayed Cutaneous Manifestations of Drug Hypersensitivity","volume":"94","author":"Bircher","year":"2010","journal-title":"Med. Clin. N. Am."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s40264-017-0522-5","article-title":"Targeting Interleukin-5 or Interleukin-5R\u03b1: Safety Considerations","volume":"40","author":"Bagnasco","year":"2017","journal-title":"Drug Saf."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1590\/abd1806-4841.20175190","article-title":"Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) and Its Relation with Autoimmunity in a Reference Center in Mexico","volume":"92","year":"2017","journal-title":"An. Bras. Dermatol."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"bcr2013201545","DOI":"10.1136\/bcr-2013-201545","article-title":"Extensive Pulmonary Involvement with Raltegravir-Induced DRESS Syndrome in a Postpartum Woman with HIV","volume":"2014","author":"Yee","year":"2014","journal-title":"BMJ Case Rep."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1056\/NEJMcpc1900595","article-title":"Case 16-2019: A 53-Year-Old Man with Cough and Eosinophilia","volume":"380","author":"Simmons","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/archdermatol.2012.1079","article-title":"Initial Presentation of DRESS: Often Misdiagnosed as Infections","volume":"148","author":"Lee","year":"2012","journal-title":"Arch. Dermatol."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"e9688","DOI":"10.1097\/MD.0000000000009688","article-title":"Drug-Induced Eosinophilic Pneumonia: A Review of 196 Case Reports","volume":"97","author":"Bartal","year":"2018","journal-title":"Medicine"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4168\/aair.2014.6.3.216","article-title":"Comparison of Diagnostic Criteria and Determination of Prognostic Factors for Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome","volume":"6","author":"Kim","year":"2014","journal-title":"Allergy Asthma. Immunol. Res."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.clindermatol.2020.06.008","article-title":"Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome","volume":"38","author":"Cardones","year":"2020","journal-title":"Clin. Dermatol."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/S0140-6736(16)30378-6","article-title":"Severe Cutaneous Adverse Reactions to Drugs","volume":"390","author":"Duong","year":"2017","journal-title":"Lancet"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaad.2018.08.052","article-title":"Drug-Induced Hypersensitivity Syndrome\/Drug Reaction with Eosinophilia and Systemic Symptoms Severity Score: A Useful Tool for Assessing Disease Severity and Predicting Fatal Cytomegalovirus Disease","volume":"80","author":"Mizukawa","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1684\/ejd.2011.1300","article-title":"Ten Cases of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Treated with Pulsed Intravenous Methylprednisolone","volume":"21","author":"Natkunarajah","year":"2011","journal-title":"Eur. J. Dermatol."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12948-016-0045-0","article-title":"Drug Induced Exfoliative Dermatitis: State of the Art","volume":"14","author":"Yacoub","year":"2016","journal-title":"Clin. Mol. Allergy"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajem.2022.03.024","article-title":"Drug Reaction with Eosinophilia and Systemic Symptoms: An Emergency Medicine Focused Review","volume":"56","author":"Gottlieb","year":"2022","journal-title":"Am. J. Emerg. Med."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/jamadermatol.2020.0048","article-title":"Evaluation of Cyclosporine for the Treatment of DRESS Syndrome","volume":"156","author":"Nguyen","year":"2020","journal-title":"JAMA Dermatol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.anai.2013.01.006","article-title":"Optimal Management of DRESS Syndrome in Course of Infectious Endocarditis","volume":"110","author":"Yacoub","year":"2013","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"709.e1","DOI":"10.1016\/j.jaad.2013.01.032","article-title":"DRESS Syndrome: Part II. Management and Therapeutics","volume":"68","author":"Husain","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/jdv.12419","article-title":"Recurrence of Drug-Induced Reactions in DRESS Patients","volume":"29","author":"Picard","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13601-020-00359-2","article-title":"Drug-Related Relapses in Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)","volume":"10","author":"Helbling","year":"2020","journal-title":"Clin. Transl. Allergy"}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/11\/2\/346\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:20:13Z","timestamp":1760120413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/11\/2\/346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,30]]},"references-count":240,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["microorganisms11020346"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms11020346","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,30]]}}}